# Migraine and Headache Studies

**Type:** Topics  
**Canonical URL:** https://scholariq.org/topics/migraine-and-headache-studies/

## Facts

| Field | Value |
| --- | --- |
| Description | This cluster of papers focuses on the pathophysiology, burden, diagnosis, treatment, and prevention of migraine and other headache disorders. It covers topics such as the role of calcitonin gene-related peptide, brain activation, trigeminal nerve function, cortical spreading depression, genetic influences, and various treatment modalities for migraine. |
| Domain | Health Sciences |
| Field | Medicine |
| OpenAlex ID | t10498 |
| Works | 325 |

## Topic papers all

Showing 15 of 325.

- [Migraine prevalence, disease burden, and the need for preventive therapy](https://scholariq.org/papers/migraine-prevalence-disease-burden-and-the-need-for-preventive-therapy/)
- [Translation, Validation, and Norming of the Dutch Language Version of the SF-36 Health Survey in Community and Chronic Disease Populations](https://scholariq.org/papers/translation-validation-and-norming-of-the-dutch-language-version-of-the-sf-36/)
- [Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II](https://scholariq.org/papers/prevalence-and-burden-of-migraine-in-the-united-states-data-from-the-american/)
- [Migraine — Current Understanding and Treatment](https://scholariq.org/papers/migraine-current-understanding-and-treatment/)
- [Safety of Transcranial Direct Current Stimulation: Evidence Based Update 2016](https://scholariq.org/papers/safety-of-transcranial-direct-current-stimulation-evidence-based-update-2016/)
- [A six-item short-form survey for measuring headache impact: The HIT-6™](https://scholariq.org/papers/a-six-item-short-form-survey-for-measuring-headache-impact-the-hit-6tm/)
- [Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability](https://scholariq.org/papers/development-and-testing-of-the-migraine-disability-assessment-midas/)
- [OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical Program](https://scholariq.org/papers/onabotulinumtoxina-for-treatment-of-chronic-migraine-pooled-results-from-the/)
- [Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials](https://scholariq.org/papers/oral-triptans-serotonin-5-ht1b-1d-agonists-in-acute-migraine-treatment-a-meta/)
- [A Controlled Trial of Erenumab for Episodic Migraine](https://scholariq.org/papers/a-controlled-trial-of-erenumab-for-episodic-migraine/)
- [Narrative Review: Reversible Cerebral Vasoconstriction Syndromes](https://scholariq.org/papers/narrative-review-reversible-cerebral-vasoconstriction-syndromes/)
- [New Appendix Criteria Open for a Broader Concept of Chronic Migraine](https://scholariq.org/papers/new-appendix-criteria-open-for-a-broader-concept-of-chronic-migraine/)
- [Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults](https://scholariq.org/papers/evidence-based-guideline-update-pharmacologic-treatment-for-episodic-migraine/)
- [Acute Migraine Medications and Evolution From Episodic to Chronic Migraine: A Longitudinal Population‐Based Study](https://scholariq.org/papers/acute-migraine-medications-and-evolution-from-episodic-to-chronic-migraine-a/)
- [Migraine: epidemiology and systems of care](https://scholariq.org/papers/migraine-epidemiology-and-systems-of-care/)

## Topic primary papers

Showing 15 of 246.

- [Migraine prevalence, disease burden, and the need for preventive therapy](https://scholariq.org/papers/migraine-prevalence-disease-burden-and-the-need-for-preventive-therapy/)
- [Prevalence and Burden of Migraine in the United States: Data From the American Migraine Study II](https://scholariq.org/papers/prevalence-and-burden-of-migraine-in-the-united-states-data-from-the-american/)
- [Migraine — Current Understanding and Treatment](https://scholariq.org/papers/migraine-current-understanding-and-treatment/)
- [A six-item short-form survey for measuring headache impact: The HIT-6™](https://scholariq.org/papers/a-six-item-short-form-survey-for-measuring-headache-impact-the-hit-6tm/)
- [Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability](https://scholariq.org/papers/development-and-testing-of-the-migraine-disability-assessment-midas/)
- [OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical Program](https://scholariq.org/papers/onabotulinumtoxina-for-treatment-of-chronic-migraine-pooled-results-from-the/)
- [Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials](https://scholariq.org/papers/oral-triptans-serotonin-5-ht1b-1d-agonists-in-acute-migraine-treatment-a-meta/)
- [A Controlled Trial of Erenumab for Episodic Migraine](https://scholariq.org/papers/a-controlled-trial-of-erenumab-for-episodic-migraine/)
- [New Appendix Criteria Open for a Broader Concept of Chronic Migraine](https://scholariq.org/papers/new-appendix-criteria-open-for-a-broader-concept-of-chronic-migraine/)
- [Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults](https://scholariq.org/papers/evidence-based-guideline-update-pharmacologic-treatment-for-episodic-migraine/)
- [Acute Migraine Medications and Evolution From Episodic to Chronic Migraine: A Longitudinal Population‐Based Study](https://scholariq.org/papers/acute-migraine-medications-and-evolution-from-episodic-to-chronic-migraine-a/)
- [Migraine: epidemiology and systems of care](https://scholariq.org/papers/migraine-epidemiology-and-systems-of-care/)
- [Fremanezumab for the Preventive Treatment of Chronic Migraine](https://scholariq.org/papers/fremanezumab-for-the-preventive-treatment-of-chronic-migraine/)
- [Migraine](https://scholariq.org/papers/migraine/)
- [Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial](https://scholariq.org/papers/safety-and-efficacy-of-erenumab-for-preventive-treatment-of-chronic-migraine-a/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.